Masoumeh Zahmatkeshan

Dr. Masoumeh Zahmatkeshan

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2019 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
HGHadi Ghaffari
Hadi Ghaffari
ATAhmad Tavakoli
Ahmad Tavakoli
AMAbdolvahab Moradi
Abdolvahab Moradi
ATAlijan Tabarraei
Alijan Tabarraei
FBFarah Bokharaei-Salim
Farah Bokharaei-Salim
AAAngila Ataei-Pirkooh
Angila Ataei-Pirkooh
Background: Currently available anti-influenza drugs are often associated with limitations such as toxicity and the appearance of drug-resistant strains. Therefore, there is a pressing need for the development of novel, safe and more efficient antiviral agents. In this study, we evaluated the antiviral activity of zinc oxide nanoparticles (ZnO-NPs) and PEGylated zinc oxide nanoparticles against H1N1 influenza virus. Methods: The nanoparticles were characterized using the inductively coupled plasma mass spectrometry, x-ray diffraction analysis, and electron microscopy. MTT assay was applied to assess the cytotoxicity of the nanoparticles, and anti-influenza activity was determined by TCID50 and quantitative Real-Time PCR assays. To study the inhibitory impact of nanoparticles on the expression of viral antigens, an indirect immunofluorescence assay was also performed. Results: Post-exposure of influenza virus with PEGylated ZnO-NPs and bare ZnO-NPs at the highest non-toxic concentrations could be led to 2.8 and 1.2 log10 TCID50 reduction in virus titer when compared to the virus control, respectively (P < 0.0001). At the highest non-toxic concentrations, the PEGylated and unPEGylated ZnO-NPs led to inhibition rates of 94.6% and 52.2%, respectively, which were calculated based on the viral loads. There was a substantial decrease in fluorescence emission intensity in viral-infected cell treated with PEGylated ZnO-NPs compared to the positive control. Conclusions: Taken together, our study indicated that PEGylated ZnO-NPs could be a novel, effective, and promising antiviral agent against H1N1 influenza virus infection, and future studies can be designed to explore the exact antiviral mechanism of these nanoparticles.

1 April 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MZMasoumeh Zahmatkeshan
Masoumeh Zahmatkeshan
FGFatemeh Gheybi
Fatemeh Gheybi
SRSeyed Mahdi Rezayat
Seyed Mahdi Rezayat
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari

12 April 2022 in Biotechnology Reports
Verified
Journal Article
Open access
MAMoein Adel
Moein Adel
MZMasoumeh Zahmatkeshan
Masoumeh Zahmatkeshan
AAAbolfazl Akbarzadeh
Abolfazl Akbarzadeh
NRNavid Rabiee
Navid Rabiee
SASepideh Ahmadi
Sepideh Ahmadi
Alexander Marcus SeifalianAlexander Marcus Seifalian
Alexander Marcus Seifalian
• In recent decades, extensive studies have been performed on breast cancer prevalence, causes, risk factors, prevention, diagnosis, and treatment. • On the other hand, traditional treatment methods suffer from limitations that prevent optimized clinical outcomes. • Different natural ingredients from various sources have shown the anticancer effects via physiological pathways. • A promising solution could be identified, including the usage of new adjuvants along with existing drugs. • Nanotechnology due to the presentation of remarkable properties has overcome this limitation through enhanced the solubility and bioavailability of AP.

9 July 2019 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
ZMZahra Hamod Marfavi
Zahra Hamod Marfavi
MFMona Farhadi
Mona Farhadi
SJSeyed Behnamedin Jameie
Seyed Behnamedin Jameie
MZMasoumeh Zahmatkeshan
Masoumeh Zahmatkeshan
VPVahid Pirhajati
Vahid Pirhajati
MJManasadat Jameie
Manasadat Jameie
Glioblastoma Multiform (GBM) known as the most common CNS malignant tumour. Therapy for GBM includes maximum tumour resection and chemotherapy. Recent advances have emphasized the use of nanoparticles, such as zinc oxide nanoparticles (ZnO-NPs). Conjugated ZnO NPs with folic acid (FA) easily pass through cell membrane. In the present study, ZnO NPs-FA applied to GBM U87MG cell line. ZnO NPs-FA synthesized according to the sol-gel method. The GBM U87MG and astrocytes 1321N1 cell lines cultured and divided into control, sham and ZnO NPs-FA groups. MTT assay used for the cell viability, and ROS assay and flow cytometry exploited. The size of nanoparticles was ≤20 nm using TEM and FTIR. After 12 hours, the viability for U87MG cells showed a significant decrease at 1.25 and 2.5 mg/ml concentrations. However, no such results obtained for astrocytes. According to the results, the ROS assay caused a significant increase in GBM cells at the mentioned concentration. It was concluded that dose-dependent conjugated NPs could play a therapeutic role in cancer therapy. GRAPHICAL ABSTRACT

1 April 2017 in Microelectronic Engineering
Verified
Journal Article
Closed access
MAMoein Adel
Moein Adel
MZMasoumeh Zahmatkeshan
Masoumeh Zahmatkeshan
BJBehrooz Johari
Behrooz Johari
SKSharmin Kharrazi
Sharmin Kharrazi
MMmehdi mehdizadeh
mehdi mehdizadeh
SRSeyed Mahdi Rezayat
Seyed Mahdi Rezayat

15 November 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MAMoein Adel
Moein Adel
PKPeyman Keyhanvar
Peyman Keyhanvar
IZIman Zare
Iman Zare
ZTZahed Tavangari
Zahed Tavangari
AAAbolfazl Akbarzadeh
Abolfazl Akbarzadeh
MZMasoumeh Zahmatkeshan
Masoumeh Zahmatkeshan